<?xml version="1.0" encoding="UTF-8"?>
<p id="para0002">It is with great interest that we read the recent article by De Francesco et al (
 <xref rid="bib0001" ref-type="bibr">1</xref>), who reported on chlamydia pneumoniae and mycoplasma pneumoniae co-infection in patients with COVID-19. Here, we report our experience with candidaemia co-infection with COVID-19. An increased incidence of candidaemia has been noted in patients with COVID-19 and although patient characteristics, investigations and antifungal therapies have been described (
 <xref rid="bib0002" ref-type="bibr">2</xref>), to our knowledge, compliance with candidaemia management bundles has not (
 <xref rid="bib0003" ref-type="bibr">3</xref>).
</p>
